相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety Evaluation of Lipid Nanoparticle-Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey
Maja Sedic et al.
VETERINARY PATHOLOGY (2018)
34S: A New Opportunity for the Efficient Synthesis of Stable Isotope Labeled Compounds
Sumei Ren et al.
CHEMISTRY-A EUROPEAN JOURNAL (2018)
Clinical Investigation of Coproporphyrins as Sensitive Biomarkers to Predict Mild to Strong OATP1B-Mediated Drug-Drug Interactions
Annett Kunze et al.
CLINICAL PHARMACOKINETICS (2018)
A Decade in the MIST: Learnings from Investigations of Drug Metabolites in Drug Development under the Metabolites in Safety Testing Regulatory Guidance
Simone Schadt et al.
DRUG METABOLISM AND DISPOSITION (2018)
Development of an LC-MS method to quantify coproporphyrin I and III as endogenous biomarkers for drug transporter-mediated drug-drug interactions
Emmanuel Njumbe Ediage et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2018)
Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans
Lina Luo et al.
PLOS ONE (2018)
UHPLC-MS/MS bioanalysis of human plasma coproporphyrins as potential biomarkers for organic anion-transporting polypeptide-mediated drug interactions
Hamza Kandoussi et al.
BIOANALYSIS (2018)
LC-MS/MS assay for N1-methylnicotinamide in humans, an endogenous probe for renal transporters
Lina Luo et al.
BIOANALYSIS (2018)
A fully automated and validated human plasma LC-MS/MS assay for endogenous OATP biomarkers coproporphyrin-I and coproporphyrin-III
Amanda King-Ahmad et al.
BIOANALYSIS (2018)
A multiplex HRMS assay for quantifying selected human plasma bile acids as candidate OATP biomarkers
Brian Rago et al.
BIOANALYSIS (2018)
Investigation of Glycochenodeoxycholate Sulfate and Chenodeoxycholate Glucuronide as Surrogate Endogenous Probes for Drug Interaction Studies of OATP1B1 and OATP1B3 in Healthy Japanese Volunteers
Issey Takehara et al.
PHARMACEUTICAL RESEARCH (2017)
2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3-LBA: immunogenicity, biomarkers and PK assays)
Shalini Gupta et al.
BIOANALYSIS (2017)
The Decennial Index of the White Papers in Bioanalysis: 'A Decade of Recommendations (2007-2016)'
Wei Garofolo et al.
BIOANALYSIS (2017)
2017 White Paper: rise of hybrid LBA/LCMS immunogenicity assays (Part 2: hybrid LBA/LCMS biotherapeutics, biomarkers & immunogenicity assays and regulatory agencies' inputs)
Hendrik Neubert et al.
BIOANALYSIS (2017)
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1-LCMS: small molecules, peptides and small molecule biomarkers)
Jan Welink et al.
BIOANALYSIS (2017)
The 10th GCC Closed Forum: rejected data, GCP in bioanalysis, extract stability, BAV, processed batch acceptance, matrix stability, critical reagents, ELN and data integrity and counteracting fraud
Stephanie Cape et al.
BIOANALYSIS (2017)
A highly selective and sensitive LC-MS/HRMS assay for quantifying coproporphyrins as organic anion-transporting peptide biomarkers
Ragu Ramanathan et al.
BIOANALYSIS (2017)
Workshop Report: Crystal City VI-Bioanalytical Method Validation for Biomarkers
Mark E. Arnold et al.
AAPS JOURNAL (2016)
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3-LBA, biomarkers and immunogenicity)
Susan Richards et al.
BIOANALYSIS (2016)
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1-small molecules, peptides and small molecule biomarkers by LCMS)
Eric Yang et al.
BIOANALYSIS (2016)
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 2-Hybrid LBA/LCMS and input from regulatory agencies)
An Song et al.
BIOANALYSIS (2016)
Advances in quantitative bioanalysis of oligonucleotide biomarkers and therapeutics
Laixin Wang et al.
BIOANALYSIS (2016)
A High-Throughput Method for Direct Detection of Therapeutic Oligonucleotide-Induced Gene Silencing In Vivo
Andrew H. Coles et al.
NUCLEIC ACID THERAPEUTICS (2016)
Enhancement of human plasma glucosylceramide assay sensitivity using delipidized plasma
Kefei Zheng et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2016)
Coproporphyrins in Plasma and Urine Can Be Appropriate Clinical Biomarkers to Recapitulate Drug-Drug Interactions Mediated by Organic Anion Transporting Polypeptide Inhibition
Yurong Lai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 2-hybrid LBA/LCMS and input from regulatory agencies)
Brad Ackermann et al.
BIOANALYSIS (2015)
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 1-small molecules by LCMS)
Jan Welink et al.
BIOANALYSIS (2015)
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3-LBA, biomarkers and immunogenicity)
Lakshmi Amaravadi et al.
BIOANALYSIS (2015)
N1-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction
Fabian Mueller et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
mRNA-based therapeutics - developing a new class of drugs
Ugur Sahin et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Multi-Level Kinetic Model of mRNA Delivery via Transfection of Lipoplexes
Thomas S. Ligon et al.
PLOS ONE (2014)
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 1-small molecules by LCMS)
Eric Fluhler et al.
BIOANALYSIS (2014)
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 2-hybrid LBA/LCMS, ELN & regulatory agencies' input)
Dawn Dufield et al.
BIOANALYSIS (2014)
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3-LBA and immunogenicity)
Lauren Stevenson et al.
BIOANALYSIS (2014)
Addressing MIST (Metabolites in Safety Testing): Bioanalytical Approaches to Address Metabolite Exposures in Humans and Animals
Hongying Gao et al.
CURRENT DRUG METABOLISM (2013)
2013 White Paper on recent issues in bioanalysis: 'hybrid' - the best of LBA and LCMS
Lauren Stevenson et al.
BIOANALYSIS (2013)
N-Methylnicotinamide Is an Endogenous Probe for Evaluation of Drug-Drug Interactions Involving Multidrug and Toxin Extrusions (MATE1 and MATE2-K)
S. Ito et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Surrogate matrix and surrogate analyte approaches for definitive quantitation of endogenous biomolecules
Barry R. Jones et al.
BIOANALYSIS (2012)
2012 White Paper on Recent Issues in Bioanalysis and Alignment of Multiple Guidelines
Binodh DeSilva et al.
BIOANALYSIS (2012)
Recommendations on biomarker bioanalytical method validation by GCC
Richard Hougton et al.
BIOANALYSIS (2012)
2011 White Paper on Recent Issues in Bioanalysis and Regulatory Findings from Audits and Inspections
Fabio Garofolo et al.
BIOANALYSIS (2011)
Recommendations on: internal standard criteria, stability, incurred sample reanalysis and recent 483s by the Global CRO Council for Bioanalysis
Steve Lowes et al.
BIOANALYSIS (2011)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
2010 White Paper on Recent Issues in Regulated Bioanalysis & Global Harmonization of Bioanalytical Guidance
Natasha Savoie et al.
BIOANALYSIS (2010)
2009 White Paper on Recent Issues in Regulated Bioanalysis from The 3rd Calibration and Validation Group Workshop
Natasha Savoie et al.
BIOANALYSIS (2010)
Bioanalysis of siRNA and oligonucleotide therapeutics in biological fluids and tissues
Guy A. Tremblay et al.
BIOANALYSIS (2009)
The 2nd Calibration and Validation Group Workshop on recent issues in Good Laboratory Practice bioanalysis
Natasha Savoie et al.
BIOANALYSIS (2009)
A PCR-based method for detection and quantification of small RNAs
Seungil Ro et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
分享论文
